HO-1, a target antioxidant enzyme of Nrf2, is critical for the protection against ischemia and reperfusion (I/R) injury in the brain, Parkinson's disease, and other neurological disorders (Calkins et al., 2009). Here, NFE2L2 is linked to nervous system disorder.